NCT00494338View on ClinicalTrials.gov

Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions

Metastatic Prostate Cancer

Interventions

DRUG

Docetaxel

Trial Locations (1)

Unknown

Sanofi-Aventis, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00494338 - Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer | Biotech Hunter | Biotech Hunter